HDT BIO CORPORATION
Development of a single-dose self-amplifying RNA vaccine for boosting pre-existing influenza virus immunity, driving B and T cell responses to conserved targets
Development of an adaptable RNA vaccine against enterovirus D68 infection for the prevention of acute flaccid myelitis
Research Project 3: Rapid-Response Roadmap for RNA vaccines